Centre for Kidney Disease Research, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Department of Nephrology and Child Health, University of Cape Town, Cape Town, South Africa.
Nephrol Dial Transplant. 2024 Sep 5;39(Supplement_2):ii18-ii25. doi: 10.1093/ndt/gfae130.
Worldwide, the uptake of peritoneal dialysis (PD) compared with hemodialysis remains limited. This study assessed organizational structures, availability, accessibility, affordability and quality of PD worldwide.
This cross-sectional study relied on data from kidney registries as well as survey data from stakeholders (clinicians, policymakers and advocates for people living with kidney disease) from countries affiliated with the International Society of Nephrology (ISN) from July to September 2022.
Overall, 167 countries participated in the survey. PD was available in 79% of countries with a median global prevalence of 21.0 [interquartile range (IQR) 1.5-62.4] per million population (pmp). High-income countries (HICs) had an 80-fold higher prevalence of PD than low-income countries (LICs) (56.2 pmp vs 0.7 pmp). In 53% of countries, adults had greater PD access than children. Only 29% of countries used public funding (and free) reimbursement for PD with Oceania and South East Asia (6%), Africa (10%) and South Asia (14%) having the lowest proportions of countries in this category. Overall, the annual median cost of PD was US$18 959.2 (IQR US$10 891.4-US$31 013.8) with full private out-of-pocket payment in 4% of countries and the highest median cost in LICs (US$30 064.4) compared with other country income levels (e.g. HICs US$27 206.0).
Ongoing large gaps and variability in the availability, access and affordability of PD across countries and world regions were observed. Of note, there is significant inequity in access to PD by children and for people in LICs.
在全球范围内,与血液透析相比,腹膜透析(PD)的采用率仍然有限。本研究评估了全球 PD 的组织架构、可及性、可及性、可负担性和质量。
本横断面研究依赖于肾脏病登记处的数据以及 2022 年 7 月至 9 月期间来自国际肾脏病学会(ISN)附属国家的利益相关者(临床医生、政策制定者和肾病患者倡导者)的调查数据。
共有 167 个国家参与了调查。79%的国家提供 PD,全球每百万人口(pmp)的中位数 PD 患病率为 21.0[四分位距(IQR)1.5-62.4]。高收入国家(HICs)的 PD 患病率是低收入国家(LICs)的 80 倍(56.2 pmp 与 0.7 pmp)。在 53%的国家,成年人的 PD 可及性高于儿童。只有 29%的国家使用公共资金(和免费)报销 PD,大洋洲和东南亚(6%)、非洲(10%)和南亚(14%)的这一比例最低。总体而言,PD 的年中位数费用为 18959.2 美元(IQR 10891.4-31013.8),4%的国家实行全额私人自付,LICs 的中位数费用最高(30064.4 美元),而其他国家收入水平(如 HICs 为 27206.0 美元)。
观察到各国和世界各地区 PD 的可用性、可及性和可负担性存在持续的巨大差距和差异。值得注意的是,儿童和 LIC 人群获得 PD 的机会存在显著不平等。